These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The role of Apligraf in the treatment of venous leg ulcers. Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970 [TBL] [Abstract][Full Text] [Related]
48. [Dermal equivalent as an inductor of the lower extremities ulcer healing]. Popandopulo AG Klin Khir; 2005 Jun; (6):27-9. PubMed ID: 16255195 [TBL] [Abstract][Full Text] [Related]
49. Characterization of a Cryopreserved Split-Thickness Human Skin Allograft-TheraSkin. Landsman A; Rosines E; Houck A; Murchison A; Jones A; Qin X; Chen S; Landsman AR Adv Skin Wound Care; 2016 Sep; 29(9):399-406. PubMed ID: 27538107 [TBL] [Abstract][Full Text] [Related]
50. [Obtaining and transplantation of the epidermis in the treatment of full-layer skin defects]. Ostrovskiĭ AA; Iupatov SI; Melamed VD; Nikitin VS Vestn Khir Im I I Grek; 1990 Mar; 144(3):94-8. PubMed ID: 2169137 [No Abstract] [Full Text] [Related]
51. Wound closure with EDC cross-linked cultured skin substitutes grafted to athymic mice. Powell HM; Boyce ST Biomaterials; 2007 Feb; 28(6):1084-92. PubMed ID: 17084446 [TBL] [Abstract][Full Text] [Related]
53. Retrospective observational analysis of the use of an architecturally unique dermal regeneration template (Derma Pure®) for the treatment of hard-to-heal wounds. Kimmel H; Gittleman H Int Wound J; 2017 Aug; 14(4):666-672. PubMed ID: 27619480 [TBL] [Abstract][Full Text] [Related]
54. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. Curran MP; Plosker GL BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767 [TBL] [Abstract][Full Text] [Related]
55. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Dinh TL; Veves A Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):152S-157S; discussion 158S-159S. PubMed ID: 16799383 [TBL] [Abstract][Full Text] [Related]
56. [Indication and clinical results of buried skin grafting to treat problematic wounds]. Kopp J; Bach AD; Kneser U; Polykandriotis E; Loos B; Krickhahn M; Jeschke MG; Horch RE Zentralbl Chir; 2004 May; 129 Suppl 1():S129-32. PubMed ID: 15168310 [TBL] [Abstract][Full Text] [Related]
57. The role of tissue engineering in wound care. Mulder GT J Wound Care; 1999 Jan; 8(1):21-4. PubMed ID: 10214195 [No Abstract] [Full Text] [Related]
58. Advances in skin grafting and treatment of cutaneous wounds. Sun BK; Siprashvili Z; Khavari PA Science; 2014 Nov; 346(6212):941-5. PubMed ID: 25414301 [TBL] [Abstract][Full Text] [Related]
59. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers. Karr J Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250 [TBL] [Abstract][Full Text] [Related]